Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine fumarate for acute optic neuritis
2018-001756-35Phase 2Unknown
- Sponsor
- University of California, San Francisco
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of clemastine and Placebo-COD Research Private Ltd in optic neuritis (ON) (2 arms), sponsored by University of California, San Francisco. Primary endpoint: P100 latency on full field transient pattern reversal visual evoked potentials. Status: unknown.
02
Drugs
clemastinePlacebo-COD Research Private Ltd
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on 2018-001756-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001756-35.